Phospholipase A2 myotoxins from Bothrops snake venoms

Toxicon

Volumn 33, Issue 11, 1995, Pages 1405-1424

  Gutiérrez, JoséMaría ^a   Lomonte, Bruno ^a  

^a UNIVERSIDAD DE COSTA RICA   (Costa Rica)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOLIPASE A; SNAKE VENOM; TOXIN; PHOSPHOLIPASE A2;

AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; DRUG EFFECT; IMMUNOLOGY; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; PATHOLOGY; REVIEW; SKELETAL MUSCLE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; MEMBRANE DAMAGE; MEMBRANE PERMEABILITY; MOUSE; MUSCLE NECROSIS; NONHUMAN; PRIORITY JOURNAL; SNAKE;

AMINO ACID SEQUENCE; ANIMALS; CROTALID VENOMS; MOLECULAR SEQUENCE DATA; MUSCLE, SKELETAL; PHOSPHOLIPASES A; TOXINS, BIOLOGICAL;

ANIMALIA; BOTHROPS; SERPENTES;

EID: 0028972997     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/0041-0101(95)00085-Z     Document Type: Review

References (129)

1. Action of heparin on the venom of Echis carinatus
2. Skeletal muscle regeneration
3. Anticoagulant effect of myotoxic phospholipase A, isolated from the venom of the snake Bothrops asper (Viperidae)
4. Degenerative and regenerative changes in murine skeletal muscle after injection of venom from the snake Bothrops asper: a histochemical and immunocytochemical study
5. Crystallization and preliminary diffraction data of two myotoxins isolated from the venoms of Bothrops asper (terciopelo) and Bothrops nummifer(jumping viper)
6. Crystal structure of a calcium-independent phospholipase-like myotoxic protein from Bothrops asper venom
7. Membrane damage by hemolytic viruses, toxins, complement, and other cytotoxic agents
8. Protection of cells against membrane damage by haemolytic agents: divalent cations and protons act at the extracellular side of the plasma membrane
9. X-ray structure at 1.55 Å of toxin γ, a cardiotoxin from Naja nigricotlis venom. Crystal packing reveals a model for insertion into membranes
10. Las serpientes venenosas de Centroamérica y el problema del ofidismo. Primera parte: aspectos zoológicos, epidemiológicos y biomédicos
11. Immunohistochemical demonstration of the binding of Bothrops asper myotoxin to skeletal muscle sarcolemma
12. 2 at 2.5 Å. Access to a shielded catalytic center
13. Specific in vitro biological activity of snake venom myotoxins
14. 2, on liposomes and mouse gastrocnemius muscle
15. 2 isolated from Bothrops asper (terciopelo) venom
16. Two distinct types of cardiotoxin as revealed by the structure and activity relationship of their interaction with zwitterionic phospholipid dispersions
17. 2
18. 2 from Naja nigricollis venom
19. Bothropstoxin-I: amino acid sequence and function
20. 2-induced oedema in rat paw
21. 2 from snake venom to human secreted forms
22. 2, anticoagulant and myotoxic activities
23. 2 from Bothrops godmani (Godman's pit viper) snake venom
24. 2, affects its pharmacologicalactivities
25. 2 reduces its membrane-destabilizing effect
26. 2 variant, from Bothrops asper snake venom
27. 2 at 1.7 Å resolution
28. 2 by heparin
29. Changes in motor endplates resulting from muscle fibre necrosis and regeneration. A light and electron microscopic study of the effects of the depolarizing fraction (cardiotoxin) of Dendroaspis jamesoni venom
30. Anti-inflammatory effects of heparin and its derivatives: inhibition of complement and of lymphocyte migration
31. Several isoforms of crotoxin are present in individual venoms from the South American rattlesnake Crotalus durissus terrificus
32. 2
33. 2 isozymes from Trimeresurus gramineus (green habu snake) venom
34. Towards understanding skeletal muscle regeneration
35. Basement membrane component changes in skeletal muscle transplants undergoing regeneration or rejection
36. Changes in the basement membrane zone components during skeletal muscle fiber degeneration and regeneration
37. Local effects induced by coral snakes (Micrurus) venoms: evidence of myonecrosis after experimental inoculation of venom from five species
38. Isolation of a myotoxin from Bothrops asper venom: partial characterization and action on skeletal muscle
39. Pathogenesis of myonecrosis induced by crude venom and a myotoxin of Bothrops asper
40. Skeletal muscle regeneration after myonecrosis induced by crude venom and a myotoxin from the snake Bothrops asper (fer-de-lance)
41. Pharmacological activities of a toxic phospholipase A isolated from the venom of the snake Bothrops asper
42. Isolation and partial characterization of a myotoxin from the venom of the snake Bothrops nummifer
43. 2 isolated from Bothrops asper venom on skeletal muscle sarcoplasmic reticulum
44. Myonecrosis induced by a basic myotoxin isolated from the venom of the snake Bothrops nummifer(jumping viper) from Costa Rica
45. Changes in myofibrillar components after skeletal muscle necrosis induced by a myotoxin isolated from the venom of the snake Bothrops asper
46. 2 isolated from the venom of the snake Bothrops jararacussu
47. Phospholipases in snake venoms and their effects on nerve and muscle
48. Natural toxins in study of degeneration and regeneration of skeletal muscle
49. Myotoxic activity of the crude venom and the principal neurotoxin, taipoxin, of the Australian taipan, Oxyuranus scutellatus
50. Pathological responses of rat skeletal muscle to a single subcutaneous injection of a toxin isolated from the venom of the Australian tiger snake, Notechis scutatus scutatus
51. Effects induced by bothropstoxin, a component from Bothrops jararacussu snake venom, on mouse and chick muscle preparations
52. 2 from Notechis scutatus scutatus venom, as directly generated by cleavage of a fusion protein produced in Escherichia coli
53. 2 from the venom of the cottonmouth snake at 2.0-Å resolution
54. Fractionation of Bothrops jararacussu snake venom: partial chemical characterization and biological activity of bothropstoxin
55. The amino acid sequence of a myotoxic phospholipase from the venom of Bothrops asper
56. Venomous snakebite in Eastern Ecuador
57. A common cytolytic region in myotoxins, hemolysins, cardiotoxins and antibacterial peptides
58. Structure-function relationships of phospholipases. II: Charge density distribution and the myotoxicity of presynaptically neurotoxic phospholipases
59. 2 homologue from Vipera ammodytes venom
60. 2 in skeletal muscle
61. 2
62. 2 homolog from the venom of Trimeresurus mucrosquamatus
63. 2 with low activity, from Trimeresurus flavoviridis venom
64. 2 purified from porcine pancreas and snake venoms
65. Individual expression patterns of myotoxin isoforms in the venom of the snake Bothrops asper
66. A new muscle damaging toxin, myotoxin II, from the venom of the snake Bothrops asper (terciopelo)
67. Production and partial characterization of monoclonal antibodies to Bothrops asper (terciopelo) myotoxin
68. Neutralization of local effects of the terciopelo (Bothrops asper) venom by blood serum of the colubrid snake Ctelia clelia
69. Isolation from a polyvalent antivenom of antibodies to a myotoxin in Bothrops asper snake venom
70. Antibody neutralization of a myotoxin from the venom of Bothrops asper (terciopelo)
71. Detection of proteins antigenically-related to Bothrops asper myotoxin in crotaline snake venoms
72. South American snake venom proteins antigenically-related to Bothrops asper myotoxins
73. Isolation of basic myotoxins from Bothrops moojeni and Bothrops atrox snake venoms
74. Equine antibodies to Bothrops asper myotoxin II: isolation from polyvalent antivenom and neutralizing ability
75. Quantitätion by enzyme-immunoassay of antibodies against Bothrops myotoxins in four commercially-available antivenoms
76. 2 from the venom of the snake Bothrops asper by monoclonal antibodies
77. Host response to Bothrops asper snake venom: analysis of edema formation, inflammatory cells, and cytokine release in a mouse model
78. The dynamics of local tissue damage induced by Bothrops asper snake venom and myotoxin II on the mouse cremaster muscle: an intravital and electron microscopic study
79. Activity of hemorrhagic metalloproteinase BaH-1 and myotoxin II from Bothrops asper snake venom on capillary endothelial cells in vitro
80. 2 from Bothrops asper snake venom by glycosaminoglycans of the heparin/heparan sulfate family
81. 2 of Bothrops asper snake venom
82. 2 from Bothrops asper snake venom. Identification of a heparin-binding and cytolytic toxin region by the use of synthetic peptides and molecular modeling
83. 2 influences penetration and substrate head-group binding, depending on the position of the acylated lysine in the enzyme molecule
84. Regeneration of mammalian skeletal muscle following the injection of the snake-venom toxin, taipoxin
85. 2 with lysine in place of aspartate 49
86. Myotoxic components of snake venoms: their biochemical and biological activities
87. 2 from crotalid venoms
88. Release of sarcoplasmic enzymes from skeletal muscle by Bothrops jararacussu venom: antagonism by heparin and by the serum of South American marsupials
89. Antagonism of the myotoxic and hemorrhagic effects of Bothrops venoms by extracts of Eclipta prostrata L., Asteraceae, and their components
90. Antagonism of the myotoxic effect of Bothrops jararacussu venom and bothropstoxin by polyanions
91. Snake toxins as antigens
92. Duchenne dystrophy: electron microscopic findings pointing to a basic or early abnormality in the plasma membrane of the muscle fiber
93. Body distribution of Bothrops asper (terciopelo) snake venom myotoxin and its relationship to pathological changes
94. Neutralization of lethal and myotoxic activities of South American rattlesnake venom by extracts and constituents of the plant Eclipta prostrata (Asteraceae)
95. Differences in distribution of myotoxic proteins in venoms from different Bothrops species
96. Isolation and comparison of myotoxins isolated from venoms of different species of Bothrops snakes
97. Neutralization of myotoxic activity of Bothrops venoms by antisera to purified myotoxins and to crude venoms
98. 2 from the venom of Bothrops jararacussu
99. 2 isozymes
100. 2 from Agkistrodon bilineatus (common cantil) venom
101. A clinical and epidemiologic study of 292 cases of lance-headed viper bite in a Brazilian teaching hospital
102. Accidente ofidico en Antioquia y Chocó. Aspectos clínicos y epidemiológicos (marzo de 1989-febrero de 1990)
103. Molecular cloning of the gene encoding a myotoxin from the venom of the broad-banded copperhead (Agkistrodon contorlrix laticinctus)
104. Cardiotoxin I from cobra (Naja naja atra) venom causes necrosis of skeletal muscle in vivo
105. Phospholipase-like myotoxins induce rapid membrane leakage of non-hydrolyzable ether-lipid liposomes
106. Autocatalytic acylation of phospholipase-like myotoxins
107. Membrane myopathy: morphological similarities to Duchenne muscular dystrophy
108. 2: a mediator between proximal and distal effectors of inflammation
109. Muscle necrosis and regeneration after envenomation by Bothrops jararacussu snake venom
110. 2 from bovine pancreas and Crotalus atrox venom
111. 2 covalently inhibited by p-bromophenacyl-bromide
112. Heparin—an introduction
113. Phospholipases
114. Symptomatology, pathology and treatment of snake bites in South America
115. Immunoenzymatic quantitation of antibodies to Bothrops asper myotoxins after polyvalent antivenom administration in mice
116. Calcium ion independent membrane leakage induced by phospholipase-like myotoxins
117. 2
118. 2 from the venom of Agkistrodon piscivorus piscivorus
119. Isolation and characterization of hemorrhagic, myonecrotic and edema-inducing toxins from Bothrops insularis (jararacailhoa) snake venom
120. Notexin-induced muscle injury in the dog
121. 2 from the venom of Australian king brown snake, Pseudechis australis.
122. 2 via substrate level acylation of lysine 56
123. 2 isoenzymes in the venoms of Central American crotaline snakes
124. 2 and their importance for enzymatic activity
125. 2 purified from human synovial fluid and inhibition by aristolochic acid
126. Basal lamina: the scaffold for orderly cell replacement. Observations on regeneration of injured skeletal muscle fibers and capillaries
127. 2 at 2.2 Å resolution
128. 2 at 2.0 Å resolution
129. 2 with low activity, from the venom of Trimeresurus flavoviridis (habu snake)